Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 46

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 46
---
 eligible employees are automatically enrolled upon joining our company unless they advise they wish to opt out. As defined by the Pensions Act, the current required contributions are 5% employee and 3% employer. We match employee contributions up to a maximum of 6%. Contributions made by us vest immediately. Employment Agreements with Our Named Executive Officers Robert Lisicki On January 3, 2024, the Company entered into an Employment Agreement with Mr. Lisicki (the “Lisicki Agreement”), effective as of January 8, 2024, under which he commenced employment with the Company in his former role of President and Chief Operating Officer. The terms of the Lisicki Agreement provide the following compensation and benefits while he is employed on an at-will basis: • Annual salary equal to $440,000. • Eligibility to earn a performance bonus of up to 40% of his annual salary, based on performance. Effective April 8, 2024, Mr. Lisicki was appointed the Company’s Chief Executive Officer and became a member of the Board. Pursuant to his appointment as Chief Executive Officer, the Board approved an increase in Mr. Lisciki’s annual salary from $440,000 to $585,000 and an increase in his target bonus opportunity from 40% of his annual base salary to 50% of his annual base salary, each effective as of April 8, 2024. Effective as of January 1, 2025, Mr. Lisicki’s annual salary was increased to $631,800 with a target bonus opportunity of 55% of his annual base salary. The terms of the Lisicki Agreement otherwise remain in effect. Under the terms of the Lisicki Agreement, the Company or Mr. Lisicki may terminate his employment with or without cause upon 90 days’ notice. The Company may, in its sole discretion, elect to pay Mr. Lisicki in lieu of permitting him to work through the notice period. Someit Sidhu On April 7, 2023, the Company entered into a Service Agreement with Dr. Someit Sidhu with respect to his former role as the Company’s Chief Executive Officer (the “Sidhu Agreement”), effective as of March 20, 2023. The terms of the Sidhu Agreement provided the following compensation and benefits while Dr. Sidhu was employed as Chief Executive Officer: 27 TABLE OF CONTENTS • Annual salary equal to $535,500 (converted from GBP